Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Phathom Pharmaceuticals Inc
PHAT
Healthcare
Biotechnology
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical...
trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:PHAT)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 23, 2025 4:15pm
New Press Release - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Anne Marie...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 23, 2025 8:00am
New Press Release - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment of Anne Marie Cook, J.D., as Chief Legal...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 16, 2025 8:00am
New Press Release - Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA) has...
read article.
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 2:02pm
PHAT ....3rd tap on the $10 Holla
Cheers !
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:24pm
PHAT.... New targets to watch for
$10.63........... Then N.H.O.D $12.19 It has to stay above $9.56 GLTA
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:21pm
PHAT.....$10.00 Holla ; )
LFG !!!!!!
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:14pm
PHAT...last at $9.84
LFG !!!!!!!!!!!!!!!
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:09pm
PHAT ....so far so good
Upside target is resistance at $9.62 Downside support is at $ 8.35 Trade accordingly
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:03pm
PHAT ....start the drumroll....has to hold $8.53
Vols are declining Wait for the dip into the gap
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:00pm
PHAT....and if it gets down and fills that gap
I will try it again....somewhere around $7.50 ish
(1034)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 06, 2025 12:57pm
RE:PHAT ....if u BTFD ...here is what u need to know ; )
Forgot....Stop loss at $8.40 because there is a big gap below that just may want to get filled
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 12:55pm
PHAT ....if u BTFD ...here is what u need to know ; )
Needs to bust thru $9.58 with vol....next target would be $10.61 LFG!
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 12:46pm
PHAT ....Great NR
BTFD
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Feb 08, 2022 9:01am
5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS
$PHAT $CYTK $ADGI $AGIO $ICPT Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF)
Sekur Private Data CEO Updates on Growth, Market Expansion, Corporate Developments and New Product Launch
Cielo Executes LOI to Advance Clean Fuels Project Development Through Strategic Asset Acquisition
A different approach to mineral exploration and development — scale, diversification & optionality
Podcasts